Eli Lilly Balance Sheet Health

Financial Health criteria checks 3/6

Eli Lilly has a total shareholder equity of $12.9B and total debt of $26.3B, which brings its debt-to-equity ratio to 204.3%. Its total assets and total liabilities are $63.9B and $51.0B respectively. Eli Lilly's EBIT is $11.8B making its interest coverage ratio 31.3. It has cash and short-term investments of $2.7B.

Key information

204.3%

Debt to equity ratio

US$26.35b

Debt

Interest coverage ratio31.3x
CashUS$2.65b
EquityUS$12.90b
Total liabilitiesUS$51.05b
Total assetsUS$63.94b

Recent financial health updates

Recent updates

5 Reasons Eli Lilly Just Keeps Rising

Jun 30

Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis)

Jun 24

Eli Lilly And Alzheimer's Disease: The Paucity Of Progress

Jun 17

Eli Lilly Continues To Climb As Alzheimer's Drug Gains FDA Approval

Jun 11

These 4 Measures Indicate That Eli Lilly (NYSE:LLY) Is Using Debt Reasonably Well

Jun 10
These 4 Measures Indicate That Eli Lilly (NYSE:LLY) Is Using Debt Reasonably Well

Eli Lilly's Growth And Challenges: A Cautious Buy

Jun 01

Eli Lilly: Addressing Supply Challenges Should Accelerate Growth

May 26

Eli Lilly: Bloated Stock

May 01

What You Can Learn From Eli Lilly and Company's (NYSE:LLY) P/S

Apr 22
What You Can Learn From Eli Lilly and Company's (NYSE:LLY) P/S

Wall Street Lunch: Lilly In Limelight

Apr 17

Eli Lilly: Diabetes And Weight Management Treatments Are The Winning Tickets

Mar 29

Eli Lilly: The Party Is Not Over

Mar 23

Estimating The Intrinsic Value Of Eli Lilly and Company (NYSE:LLY)

Mar 17
Estimating The Intrinsic Value Of Eli Lilly and Company (NYSE:LLY)

Eli Lilly: Yes, It Is Too Late To Join The Party

Feb 20

Eli Lilly: Overvaluation Is A Big Red Flag

Feb 14

Eli Lilly and Company: Even 'Miracle Drugs' Can't Keep Stock Rising (Downgrade)

Feb 07

Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value

Jan 31

Eli Lilly (NYSE:LLY) Has Announced That It Will Be Increasing Its Dividend To $1.30

Jan 24
Eli Lilly (NYSE:LLY) Has Announced That It Will Be Increasing Its Dividend To $1.30

Eli Lilly: The Cupboard Is Fully Stocked

Jan 19

Eli Lilly: The Buzz Is Not Over

Jan 11

Eli Lilly (NYSE:LLY) Is Increasing Its Dividend To $1.30

Jan 10
Eli Lilly (NYSE:LLY) Is Increasing Its Dividend To $1.30

Eli Lilly (NYSE:LLY) Is Paying Out A Larger Dividend Than Last Year

Dec 27
Eli Lilly (NYSE:LLY) Is Paying Out A Larger Dividend Than Last Year

Pinning Down Eli Lilly and Company's (NYSE:LLY) P/S Is Difficult Right Now

Dec 24
Pinning Down Eli Lilly and Company's (NYSE:LLY) P/S Is Difficult Right Now

Eli Lilly: Long Path To A Trillion

Dec 21

Financial Position Analysis

Short Term Liabilities: LLY's short term assets ($25.2B) exceed its short term liabilities ($18.6B).

Long Term Liabilities: LLY's short term assets ($25.2B) do not cover its long term liabilities ($32.4B).


Debt to Equity History and Analysis

Debt Level: LLY's net debt to equity ratio (183.7%) is considered high.

Reducing Debt: LLY's debt to equity ratio has reduced from 624% to 204.3% over the past 5 years.

Debt Coverage: LLY's debt is not well covered by operating cash flow (14%).

Interest Coverage: LLY's interest payments on its debt are well covered by EBIT (31.3x coverage).


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.